..

ஜர்னல் ஆஃப் நீரிழிவு சிக்கல்கள் & மருத்துவம்

ஐ.எஸ்.எஸ்.என்: 2475-3211

திறந்த அணுகல்
கையெழுத்துப் பிரதியை சமர்ப்பிக்கவும் arrow_forward arrow_forward ..

தொகுதி 8, பிரச்சினை 3 (2023)

மினி விமர்சனம்

Advancements in Diabetes Research and Clinical Practice: A Journey towards Improved Management and Prevention

Khegay Hendy

Diabetes mellitus, a chronic metabolic disorder characterized by elevated blood glucose levels, has reached epidemic proportions globally. With its rising prevalence and profound impact on health, extensive research efforts have been dedicated to understanding, managing and preventing diabetes. Over the years, significant progress has been made in diabetes research and clinical practice, leading to improved diagnostic tools, therapeutic strategies and lifestyle interventions. This article aims to shed light on recent advancements in diabetes research and their potential implications for clinical practice.

ஆய்வுக் கட்டுரை

Cyclosporine Nephrotoxicity in Patients with Type 1 Diabetes Mellitus Arbitrary Verdict: A Meta-Analysis of Randomized Control Trials

Ahmed M El-Malky, Ramachandra G Naik

Background: Disturbance in renal function was considered to be a common complication of Cyclosporine-A (CsA) treated patients of recent-onset type 1 diabetes mellitus, for purposes of remission. The aim of the present study was to scrutinize the potential association between this drug and its complications by conducting a meta-analysis of randomized control trials.

Methods: A consummate literature search of PubMed, EMBASE, and web of science was conducted until March 2019. A total of 9 randomized control trials were included in this meta-analysis.

Results: On meta-analysis of nine studies evaluating the risk of transient complications, analysis of the random effect of 12 months-low dose-cyclosporine on serum creatinine, revealed the absence of CsA induced nephrotoxicity. And no association between CsA and renal function in newly diagnosed type 1 diabetic patients Odds Ratio (OR), 1.06; 95% Confidence Interval (CI), 1.00-1.43; I2=73.1%). No noteworthy publication bias was noticed in the designated 9 studies.

Conclusion: 12 months low dose CsA was not associated with risk of deterioration of renal function according to the results revealed from the meta-analysis of RCTs which is considered as the summit of the research pyramid.

ஜர்னல் ஹைலைட்ஸ்

குறியிடப்பட்டது

arrow_upward arrow_upward